Biomedical Engineering Reference
In-Depth Information
melanoma cells expressing firefly and sea pansy luciferases.
J Control
Release
, 2005.
105
(3): pp. 332-343.
75. Takeshita, F.,
., Efficient delivery of small interfering RNA to bone-
metastatic tumors by using atelocollagen
et al
in vivo
.
Proc Natl Acad Sci
(34): pp. 12177-12182.
76. Sah, D.W., Therapeutic potential of RNA interference for neurological
disorders.
USA
, 2005.
102
Life Sci
, 2006.
79
(19): pp. 1773-1780.
77. Elbashir, S.M.,
., Duplexes of 21-nucleotide RNAs mediate RNA
interference in cultured mammalian cells.
et al
Nature
, 2001.
411
(6836):
pp. 494-498.
78. de Fougerolles, A.,
et al
., RNA interference
in vivo
: toward synthetic
small inhibitory RNA-based therapeutics.
Methods Enzymol
, 2005.
: pp. 278-296.
79. Schiffelers, R.M.,
392
., Cancer siRNA therapy by tumor selective
delivery with ligand-targeted sterically stabilized nanoparticle.
et al
Nucleic
(19): p. e149.
80. Li, S.D., and L. Huang, Surface-modified LPD nanoparticles for tumor
targeting.
Acids Res
, 2004.
32
: pp. 1-8.
81. Li, S.D., and L. Huang, Nanoparticles evading the reticuloendothelial
system: role of the supported bilayer.
Ann N Y Acad Sci
, 2006.
1082
Biochim Biophys Acta
, 2009.
(10): pp. 2259-2266.
82. Abra, R.M., M.E. Bosworth, and C.A. Hunt, Liposome disposition
1788
in
vivo
: effects of pre-dosing with lipsomes.
Res Commun Chem Pathol
(2): pp. 349-360.
83. Moghimi, S.M., and S.S. Davis, Innovations in avoiding particle clearance
from blood by Kupffer cells: cause for reflection.
Pharmacol
, 1980.
29
Crit Rev Ther Drug
(1): pp. 31-59.
84. Chrastina, A., K.A. Massey, and J.E. Schnitzer, Overcoming
Carrier Syst
, 1994.
11
in vivo
barriers to targeted nanodelivery.
Wiley Interdiscip Rev Nanomed
Nanobiotechnol
, 2011.
3
(4): pp. 421-437.
85. Uster, P.S.,
., Insertion of poly(ethylene glycol) derivatized
phospholipid into pre-formed liposomes results in prolonged
et al
in vivo
circulation time.
FEBS Lett
, 1996.
386
(2-3): pp. 243-246.
86. Yu, B.,
et al
., Receptor-targeted nanocarriers for therapeutic delivery
to cancer.
Mol Membr Biol
, 2010.
27
(7): pp. 286-298.
87. Templeton, N.S.,
., Improved DNA: liposome complexes for
increased systemic delivery and gene expression.
et al
Nat Biotechnol
,
1997.
15
(7): pp. 647-652.
Search WWH ::
Custom Search